>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
白细胞介素-33对肝癌细胞迁移、侵袭能力和细胞骨架的影响
作者:李凡  夏兵祥  徐健  张业伟 
单位:南京医科大学附属肿瘤医院 普外科, 江苏 南京 210009
关键词:白细胞介素-33 肝癌细胞 细胞迁移侵袭 细胞骨架 
分类号:R735.7
出版年·卷·期(页码):2018·37·第三期(365-371)
摘要:

目的:探讨白细胞介素(IL)-33对肝癌细胞迁移能力、侵袭能力和细胞骨架的影响及其作用机制。方法:通过蛋白质印迹法检测肝癌细胞中β-链蛋白、基质金属蛋白酶(MMP)-2以及MMP-9蛋白表达水平,流式细胞仪分析肝癌细胞表面抗原分子的表达水平,附壁试验和细胞聚集试验分别检测肝癌细胞对细胞外基质的亲和力以及肝癌细胞的聚集能力,细胞迁移划痕实验和穿透小室法测定IL-33对肝癌细胞体外迁移侵袭能力的影响,高内涵细胞分析系统免疫荧光法检测IL-33对肝癌细胞骨架的影响。结果:在IL-33的作用下,肝癌细胞中β-链蛋白、MMP-2以及MMP-9蛋白的表达均显著下降(P<0.05),并有剂量和时间依赖性。与对照组相比,经IL-33作用后肝癌细胞间黏附分子-1、人类白细胞抗原-Ⅰ的表达率显著增加,且CD44表达显著下降(P<0.05);肝癌细胞对细胞外基质的亲和力及肝癌细胞聚集程度均降低(P<0.05);实验组肝癌细胞的微丝数量和细胞骨架的面积显著降低,且与剂量相关(P<0.05)。结论:IL-33能够有效抑制肝癌细胞的迁移和侵袭,并且有降低细胞骨架微丝数量和面积的作用。

Objective: To investigate the mechanism and effects of interleukin-33(IL-33) on the migration, invasion and cytoskeleton of human hepatoma carcinoma cells.Methods: The protein expression levels of β-catenin, matrix metalloproteinase-2(MMP-2) and matrix metalloproteinase-9(MMP-9) in hepatoma carcinoma cells were detected by Western blotting. The expression of antigenic molecules was analyzed by flow cytometer. The tumor cell binding affinity to extracellular matrix components and the degree of homotypic aggregation were measured by cell attachment and aggregation assay, respectively. The invasive and migratory abilities of IL-33 were detected by Transwell migration assay and wound healing assay, respectively. The effect of IL-33 on cytoskeleton was evaluated by high intension cell analysis system.Results: The expression of β-catenin, MMP-2 and MMP-9 were significant decreased in experimental group than those in control group in a dose and time dependent manner after the IL-33 treatment(P<0.05). Compared with control group, the expression of ICAM-1, HLA-Ⅰ increased significantly while the CD44 was significantly decreased(P<0.05). And the binding affinity to extracellular matrix components and the degree of homotypic aggregation were significantly decreased after IL-33 treatment. The microfilament cytoskeleton and the area of cytoskeleton decreased more significantly than those in control group(P<0.05).Conclusion: The IL-33 can effectively suppress the invasion and migration of hepatoma carcinoma cell, and reduce the amount of microfilament and the area of cytoskeleton.

参考文献:

[1] SIEGEL R L,MILLER K D,JEMAL A.Cancer statistics,2017[J].CA Cancer J Clin,2017,67(1):7-30.
[2] 王晶宇,王一辰,王丽,等.盐霉素对肝癌HepG2细胞体外增值和侵袭转移能力的影响[J].中国细胞生物学学报,2013,35(5):655-660.
[3] 彭贵勇,庞政.IFN-γ对人肝癌细胞侵袭及转移的调节作用[J].基础医学与临床,2001,21(6):531-533.
[4] DVORKIN T,SONG X,ARGOV S,et al.Immune phenomena involved in the in vivo regression of fibrosarcoma cells expressing cell-associated IL-1 alpha[J].J Leukoc Biol,2006,80(1):96-106.
[5] 毕蕾,颜晓静,杨烨,等.川芎嗪对肝癌HepG2细胞迁移、侵袭和细胞骨架的影响[J].中国药理学通报,2016(2):194-198.
[6] FUCHS D,DANIEL V,SADEGHI M,et al.Salinomycin overcomes ABC transporter-mediated multidrug and apoptosis resistance in human leukemia stem cell-like KG-1a cells[J].Biochem Biophys Res Commun,2010,394(4):1098-1104.
[7] COSTANTINI S,di BERNARDO G,CAMMAROTA M,et al.Gene expression signature of human HepG2 cell line[J].Gene,2013,15(2):335-345.
[8] 彭贵勇,庞政.IL-4对人肝癌细胞侵袭力及转移力的调节作用[J].中国肿瘤生物治疗杂志,2001,8(2):190-192.
[9] 马超,赵继志,张韬,等.细胞黏附分子-1和淋巴细胞功能相关抗原在口腔鳞癌中的表达及其临床意义[J].中国药物与临床,2015,15(9):1337-1339.
[10] 张桂蓉.CD44与肿瘤的关系[J].重庆医学,2002,31(4):342-344.
[11] HARADA N,MIZOI T,KINOUCHI M,et al.Introduction of antisense CD44S cDNA down regulated expression of overall CD44 isoforms and inhibits tumor growth and metastasis in highly metastatic colon carcinoma[J].Int J Cancer,2001,91(1):67-73.
[12] PALMER G,GABAY C.Interleukin-33 biology with potential insights into human diseases[J].Nat Rev Rheumatol,2011,7(6):321-329.
[13] SMITHGALL M D,GOMEAU M R,YOON B R,et al.IL-33 amplifies both Th1-and Th2-type response through its activity on human basophiles,allergen reactive Th2 cells,iNKT and NK cells[J].Int Immunol,2008,20(8):1019-1030.
[14] HUMPHREYS N E,DAMO X U,HEPWORTH M R,et al.IL-33,a potent inducer of adaptive immunity to intestinal nematodes[J].J Immunol,2008,180(4):2443-2449.
[15] YILMAZ M,CHRISTOFORI G.Mechanisms of motility in metastasizing cells[J].Mol Cancer Res,2010,8(5):692-642.
[16] TIEN L T,ITO M,NAKAO M,et al.Expression of betacatenin in hepatocellular carcinoma[J].World J Gastroenterol,2005,11(16):2398-2401.
[17] MEI J M,BORCHERT G L,DONALD S P.Matrix metalloproteinase(s) mediate(s) NO-induced dissociation of beta-catenin from membrane bound Ecadherin and formation of nuclear beta-catenin/LEF-1 complex[J].Carcinogenesis,2002,23(12):2119-2122.
[18] SHUMAN-MOSS L A,JENSEN-TAUBMAN S,STETLER-STEVENSON W G.Matrix metallo-proteinases:changing roles in tumor progression and metastasis[J].Am J Pathol,2012,181(6):1895-1899.
[19] 邓少源.血清MMP-7和MMP-2联合肝癌预测预后的价值及其与肝癌浸润转移的关系[J].现代医学,2016,44(7):961-964.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 251065 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-87232481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364